RERBX
Price
$61.34
Change
-$0.33 (-0.54%)
Updated
Oct 7 closing price
Net Assets
138.4B
REREX
Price
$63.52
Change
-$0.34 (-0.53%)
Updated
Oct 7 closing price
Net Assets
138.4B
Interact to see
Advertisement

RERBX vs REREX

Header iconRERBX vs REREX Comparison
Open Charts RERBX vs REREXBanner chart's image
American Funds EUPAC R2
Price$61.34
Change-$0.33 (-0.54%)
VolumeN/A
Net Assets138.4B
American Funds EUPAC R4
Price$63.52
Change-$0.34 (-0.53%)
VolumeN/A
Net Assets138.4B
RERBX vs REREX Comparison Chart in %
View a ticker or compare two or three
VS
RERBX vs. REREX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RERBX is a Buy and REREX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERBX (138B) and REREX (138B) have equal amount of cash in the bank . REREX pays higher dividends than RERBX: REREX (0.68) vs RERBX (0.24). RERBX was incepted earlier than REREX: RERBX (23 years) vs REREX (23 years). RERBX (1.56) is less costly to investors than REREX (0.82). RERBX (35.00) and REREX (35.00) have comparable annual turnover. RERBX (250) and REREX (250) have matching initial minimum investment requirements. REREX annual gain was more profitable for investors over the last year : 10.07 vs. RERBX (9.07). REREX return over 5 years is better than : 13.55 vs. RERBX (9.62).
RERBXREREXRERBX / REREX
Total Expense Ratio1.560.82190%
Annual Report Gross Expense Ratio1.560.82190%
Fund Existence23 years23 years-
Gain YTD20.62921.43096%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets138B138B100%
Annual Yield % from dividends0.240.6835%
Returns for 1 year9.0710.0790%
Returns for 3 years46.4349.4794%
Returns for 5 years9.6213.5571%
Returns for 10 years36.4042.1886%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TELA1.570.06
+3.63%
TELA Bio
THM1.870.05
+2.75%
International Tower Hill Mines Ltd
VRDN21.000.17
+0.82%
Viridian Therapeutics
OACCU10.65N/A
N/A
Oaktree Acquisition Corp III Life Sciences
CRL170.10-4.85
-2.77%
Charles River Laboratories International